Modular Cre/lox system and genetic therapeutics for colorectal cancer.
The Cre/lox system is a powerful tool for targeting therapeutic effectors in a wide variety of human disorders. I review a Cre/lox Wnt-targeted system that has shown promise against Wnt-positive colorectal cancer cell lines. In addition to Wnt-specific targeting of cell death inducers, the modular nature of this gene therapy model system can be exploited by designing positive and negative feedback loops to either amplify or inhibit Wnt activity for experimental or therapeutic benefit. I discuss the structural components and performance parameters of the system, the implication of these findings with respect to cancer stem cells, as well as the general applicability of this system to any disorder characterized by differential gene expression. I also consider the issue of gene delivery as well as in vivo testing requirements necessary for the further characterization and development of this system.
Bordonaro
Michael
M
Department of Basic Sciences, The Commonwealth Medical College, 501 Madison Avenue, Scranton, PA 18510, USA. mbordonaro@tcmedc.org
D015179:Colorectal Neoplasms / Q000235:genetics* / Q000628:therapy*; D004742:Enhancer Elements, Genetic; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D019426:Integrases / Q000235:genetics*; D011401:Promoter Regions, Genetic
C045073:Cre recombinase; D019426:Integrases